98.5%
tezepelumabreslizumabdupilumabomalizumabbenralizumabsevere asthma
…the only without polysorbate). Consequently, desensitisation to tezepelumab was proposed.Results The content of the commercial pen (CP) (21…
3articles mentioning drugs
3drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: reslizumab ×
reslizumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning reslizumab
3 articles · page 1 of 1dupilumabmepolizumabtezepelumabreslizumabbenralizumabSUAnasal polyposisbiologic therapyatopic dermatitisbiologic treatment+1 more
…and nasal polyposis 29.2% (12/41). Biologic therapies used were dupilumab 48.7% (20/41), benralizumab 24.4% (10/41), tezepelumab 12.2% (5…
tezepelumabbenralizumabmepolizumabdupilumabreslizumabomalizumabsevere asthma
…enralizumab, dupilumab, mepolizumab, omalizumab, reslizumab and tezepelumab, were estimated using Medicine Carbon Footprint Classifier, a s…